Home> Links

Policies Interpretation

Policy interpretation of the NMPA Announcement on Measures to Optimize the Management of Safety Assessment of Cosmetics
Major progress in drug review and evaluation in 2022
First China-led international standard for COVID-19 prevention and control medical devices